Operator: Greetings, and welcome to the electroCore Third Quarter 2023 Earnings Conference Call. At this time, all participants on a listen only mode. Please make sure to mute yourself.
Alcohol use is not associated with lower odds of sustained virologic response among patients initiating direct-acting antiviral therapy for chronic HCV infection.
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.
Alcohol use is not associated with lower odds of SVR among patients initiating direct-acting antiviral therapy for chronic hepatitis C virus infection.
Oral Lipid Nanoparticle Drug Shields Against Colitis Cancer: Study miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.